3:50 PM
 | 
Jul 10, 2018
 |  BC Extra  |  Company News

Tasly Biopharmaceuticals gains control of JV ahead of possible IPO

Tasly Biopharmaceuticals Co. Ltd. (Shanghai, China) gained full control of its JV with Transgene S.A. (Euronext:TNG) and said it plans to list on the Hong Kong stock exchange. Tasly gained full rights in China, including Hong Kong and Macau, and...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >